Stay updated on Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.

Latest updates to the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new version entry, Revision: v3.6.3, was added to the Record History, and the previous Revision: v3.6.2 entry was removed from the tracked changes.SummaryDifference0.1%

- Check25 days agoChange DetectedA new revision entry v3.6.2 was added to the study record history. The previous revision v3.6.0 was removed.SummaryDifference0.1%

- Check39 days agoChange DetectedDifference0.4%

- Check46 days agoChange DetectedA new revision (v3.5.5) has been added to the record history, replacing the previous revision (v3.5.4). This reflects an update to the page version within ClinicalTrials.gov's history tracking.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision history now shows v3.5.4 replacing the previous v3.5.3. This indicates the study record has been updated to a newer version.SummaryDifference0.1%

- Check83 days agoChange DetectedActive, not recruiting replaces the previous Recruiting status, indicating enrollment is paused or closed. The update also introduces related sections (Contacts/Locations, Oversight, Study Status, Study Identification) and records 2026-05-01 as the latest update, superseding the 2024-12-09 entry.SummaryDifference1%

Stay in the know with updates to Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.